https://www.sciencedaily.com/releases/2016/09/160914095610.htm
Physicians at Rush University Medical Center became the first in Illinois to inject AST-OPC1 (oligodendrocyte progenitor cells), an experimental treatment, into the damaged cervical spine of a recently paralyzed man as part of a multicenter clinical trial. Dr. Richard G. Fessler, professor of neurological surgery at Rush University …